Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Change in Account Payables (2020 - 2025)

Journey Medical's Change in Account Payables history spans 6 years, with the latest figure at -$2.7 million for Q4 2025.

  • For the quarter ending Q4 2025, Change in Account Payables fell 480.59% year-over-year to -$2.7 million, compared with a TTM value of -$7.2 million through Dec 2025, down 242.97%, and an annual FY2025 reading of -$7.2 million, down 242.97% over the prior year.
  • Change in Account Payables for Q4 2025 was -$2.7 million at Journey Medical, down from -$1.2 million in the prior quarter.
  • The five-year high for Change in Account Payables was $9.5 million in Q3 2021, with the low at -$11.9 million in Q2 2023.
  • Average Change in Account Payables over 5 years is -$360450.0, with a median of -$86500.0 recorded in 2021.
  • Year-over-year, Change in Account Payables skyrocketed 736.04% in 2022 and then tumbled 511.99% in 2023.
  • Tracing DERM's Change in Account Payables over 5 years: stood at -$5.5 million in 2021, then surged by 153.88% to $2.9 million in 2022, then plummeted by 440.18% to -$10.0 million in 2023, then soared by 107.1% to $711000.0 in 2024, then plummeted by 480.59% to -$2.7 million in 2025.
  • Per Business Quant, the three most recent readings for DERM's Change in Account Payables are -$2.7 million (Q4 2025), -$1.2 million (Q3 2025), and -$1.6 million (Q2 2025).